P2X7 inhibition in vitro and in vivo decreased the expression of some negative prognostic cancer markers: pro-survival proteins, EMT-related proteins as well as decreased the ATP level, and ROS production in glioma C6 cells. The gene discussed is P2RX7; the disease is central nervous system cancer.